Response to B-cell depletion therapy for lupus predicted by biomarkers

8 August 2008 Print this article Comments Share this article
Patients with active refractory systemic lupus erythematosus  (SLE) and an expanded autoantibody profile with raised BLyS levels have shorter responses to B cell depletion therapy (BCDT), according to a recent investigation....

Want to read complete article? Please Sign in or Register.

Most viewed articles this week

Recent comments

Related sites